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Abstract Primary brain calcification (PBC) is a neurodegen-
erative disorder characterized by calcium-phosphate deposits
in the basal ganglia and often also other areas of the brain. The
prevalent clinical manifestations are cognitive impairment,
neuropsychiatric symptoms, and movement disorders. In re-
cent years, monoallelic variants in SLC20A2, which encodes
the type III sodium-dependent inorganic phosphate (Pi) trans-
porter 2 (PiT2), have been linked to the familial form of PBC
in 40–50% of the families reported worldwide as well as to
sporadic cases of PBC. Further insight into the disease mech-
anism is, however, needed. Based on co-expression studies of
wild-type and variant PiT2 in Xenopus laevis oocytes, the
molecular disease mechanism associated with SLC20A2 mis-
sense variants has formerly been suggested to be
haploinsufficiency. We have here used mammalian cells iso-
lated from a Slc20a2−/− mouse and co-expression of human
wild-type and variant PiT2. Two of the variants studied have
both been reported twice in unrelated PBC cases: PiT2D28N
in two sporadic cases and PiT2E575K in a familial and a
sporadic case. We find that in mammalian cells, the analyzed
SLC20A2 missense variants can exert their effect in a domi-
nant negative manner resulting in decreased wild-type PiT2 Pi
transport. Thus, compared to monoallelic lack of functional
PiT2 protein expression, which reasonably points towards
haploinsufficiency, certain SLC20A2 missense variants may
be more detrimental for cellular Pi uptake and potentially
contribute to an earlier disease onset and/or a more severe
phenotype as observed for Slc20a2−/− mice compared to
Slc20a2+/− mice.
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Introduction
Primary familial brain calcification (PFBC) (OMIM:
#213600, #616413, #615007, and #615483), formerly known
as BFahr’s disease^ or familial idiopathic basal ganglia calci-
fication (FIBGC), is a rare autosomal dominant inherited neu-
rodegenerative disease. It is characterized by bilateral calcifi-
cations in the basal ganglia, but other areas of the brain are
also often affected. Primary refers to that the calcifications are
not secondary to systemic diseases, infections, traumas, or
toxicity (Sobrido et al. 2014; Westenberger and Klein 2014).
The symptoms associated with PFBC are heterogeneous with
the most prevalent being cognitive impairment (ranging from
mild cognitive impairment to dementia), neuropsychiatric
symptoms (e.g., mood disorders and psychotic signs), and
movement disorders (often parkinsonism), but other symp-
toms as migraine and speech disorders can also be present
(Manyam et al. 2001; Nicolas et al. 2013a; Sobrido et al.
2014; Yamada et al. 2014; Nicolas et al. 2015). The age of
onset of clinical symptoms is also diverse and ranges from
early childhood to old age (Nicolas et al. 2013a; Sobrido
et al. 2014; Nicolas et al. 2015).
The gene SLC20A2 encodes a member of the inorganic
phosphate (Pi) transport (PiT) family (TC#2.A.20), the type
III sodium-dependent Pi transporter 2 (PiT2) (Kavanaugh
et al. 1994; Kavanaugh and Kabat 1996; Bai et al. 2000).
PiT2 is ubiquitously expressed in mammalian cells and
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assigned a role in cellular Pi homeostasis and, recently, in
maintaining the lower Pi concentration in the cerebrospinal
fluid (CSF) compared to the blood (Kavanaugh et al. 1994;
Uckert et al. 1998; Guerreiro et al. 2014; Jensen et al. 2016). In
2012, Wang et al. linked a deletion and five missense variants
in SLC20A2, all resulting in PiT2 proteins with impaired Pi-
transport function, as well as a SLC20A2 frameshift variant to
PFBC (Wang et al. 2012). It was later confirmed that knockout
(KO) of PiT2 in mice indeed led to brain calcifications, which
could be found associated with the vasculature as observed in
autopsied PFBC patients (Miklossy et al. 2005; Wider et al.
2009; Jensen et al. 2013). Variants in three other genes have
also been associated with PFBC: the genes encoding the
platelet-derived growth factor receptor β (PDGF-Rβ) and its
main ligand, PDGF-B (Keller et al. 2013; Nicolas et al.
2013b), and lately, the gene encoding the Pi exporter, XPR1
(Legati et al. 2015). SLC20A2 variants are present in 40 to
50% of the PFBC families (Hsu et al. 2013; Yamada et al.
2014), which makes variants in this gene a prime cause of
PFBC. In addition, SLC20A2 variants are also linked to spo-
radic cases of primary brain calcification (PBC), confirmed or
not confirmed as de novo variants (Schottlaender et al. 2012;
Chen et al. 2013; Nicolas et al. 2013a; Ferreira et al. 2014;
Westenberger and Klein 2014; Lemos et al. 2015).
Human PiT2 (NP_006740.1) is a 652-amino acid long pro-
tein (van Zeijl et al. 1994). The N- and C-terminal parts are
multi-membrane spanning and connected with a large intra-
cellular domain comprising approximately half the protein
(van Zeijl et al. 1994). Since 2012, various kinds of variants
in SLC20A2 have been reported linked to familial and sporad-
ic PBCs, e.g., missense, frameshift, deletions, nonsense, and
splice site (Schottlaender et al. 2012; Wang et al. 2012; Chen
et al. 2013; Hsu et al. 2013; Lemos et al. 2013; Nicolas et al.
2013a; Ferreira et al. 2014; Taglia et al. 2014; Westenberger
and Klein 2014; Yamada et al. 2014; Lemos et al. 2015;
Nicolas et al. 2015; Liu et al. 2016). They are in general
scattered over the coding sequence with the exception of exon
6, which is predicted to encode the transmembrane region
positioned immediately N-terminal to the large intracellular
domain (Bøttger and Pedersen 2011; Westenberger and
Klein 2014; Lemos et al. 2015). More than 50% of the pres-
ently reported SLC20A2 variant types are missense variants
(Westenberger and Klein 2014; Lemos et al. 2015). Of these,
the missense variants p.Asp28Asn (PiT2D28N) and
p.Glu575Lys (PiT2E575K) had previously been investigated
and shown not to support Pi uptake in Xenopus laevis oocytes
(Bøttger and Pedersen 2002, 2005); D28 and E575 were orig-
inally selected for investigation due to their high degree of
phylogenetic conservation with D28 being part of the N-
terminal PiT family signature sequence (Bøttger and
Pedersen 2002, 2005). In their seminal study of PFBC fami-
lies reported in 2012, Wang et al. identified PiT2E575K as
well as additional SLC20A2 missense variants, which they
also found not to support Pi uptake in Xenopus oocytes
(Wang et al. 2012). The authors furthermore analyzed whether
PiT2E575K and the missense variant p.Ser601Trp
(PiT2S601W) acted in dominant negative manners on the Pi-
uptake function of wild-type (WT) PiT2 by co-injection of
complementary RNAs encoding WT PiT2 and either of the
two variants at a 1:1 ratio and found this not to be the case
(Wang et al. 2012). Therefore, the general view of how
SLC20A2 variants can lead to disease is by haploinsufficiency
(Westenberger and Klein 2014; Lemos et al. 2015). In the
cases where there is no protein expression from the variant
allele, haploinsufficiency is the likely disease mechanism. It
has, however, been shown that PiT2 can form functional olig-
omers in mammalian cells and, using Pi-transport-incompe-
tent PiT2 proteins, that the oligomerization per se is indepen-
dent of PiT2’s Pi-transport ability (Salaün et al. 2002; Salaün
et al. 2004). Moreover, kinetic analysis of human PiT2
expressed in Xenopus oocytes by Bøttger et al. revealed pos-
itive cooperativity (Hill coefficient of 2) (Bøttger et al. 2006),
thus further suggesting that the transporting form of PiT2 is a
dimer. It can, however, also be observed that the molecular
weight of human PiT2 oligomers isolated from Xenopus oo-
cytes seems to be lower than that of oligomers isolated from
mammalian cells (Bøttger and Pedersen 2002; Salaün et al.
2002; Salaün et al. 2004; Bøttger and Pedersen 2005), which
might implicate, e.g., post-translational processing in mam-
malian cells. There are indeed differences between Xenopus
oocytes and mammalian cells, e.g., in membrane composition
and expression levels of endogenous proteins (Wagner et al.
2000; Hill et al. 2005). Thus, albeit that Pi-transport-incompe-
tent PiT2 variants linked to PBC have been reported not to
affect the Pi-transport of WT PiT2 in Xenopus oocytes, we
wished to address whether Pi-transport-incompetent PiT2 var-




(Slc20a2+/−) mice obtained from the European Mouse
Mutant Archive (EMMA) in Germany have been described
p r e v i o u s l y ( h t t p : / / w w w . k n o c k o u t m o u s e .
org/martsearch/project/24503) (Jensen et al. 2013). The mice
were handled according to the Danish law on animal experi-
mentation and the animal welfare policy at Aarhus University.
The strain is heterozygous for the KO cassette, L1L2-PGK-P,
which introduces splice acceptor and SV40 polyadenylation
sequences in Slc20a2 between the third and fourth exons (i.e.,
the second and third coding exons). Skin fibroblasts (3463T3)
were obtained from a mouse homozygous for the KO cassette
(Slc20a−/− mice); further characterization of the Slc20a−/−
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cells will be published elsewhere. The cells were cultivated in
Dulbecco’s modified eagle’s medium (DMEM) with pyruvate
(Gibco, Life Technologies) supplemented with 15% fetal bo-
vine serum (Gibco) and 1% penicillin and streptomycin
(Gibco).
Transfection
The eukaryotic expression vector pcDNA1ARtkpA
encoding WT human PiT2 (pOJ74) or Pi-transport-KO mu-
tants (pOJ74D28N, pOJ74H502A, and pOJ74E575K) have
been described (Pedersen et al. 1995; Bøttger and Pedersen
2002, 2005, 2011). Cells were seeded in four-well plates
(NUNC, Hounisen) at a density of 1.5 × 104 cells/cm2 and
incubated for 24 h before they were transfected using the
Lipofectamine® 2000 reagent (Invitrogen™, Thermo
Fisher Scientific) at a DNA/transfection reagent ratio of
1:3. This optimal ratio for transfection was determined by
transfecting the cells with a eukaryotic expression vector
encoding enhanced green fluorescent protein (pEGFP-N1
(Clontech)). DNAs of similar quality of pOJ74 and
pOJ74D28N, pOJ74H502A, or pOJ74E575K were mixed
in equimolar or different ratios. In order to avoid promotor
competition, empty vector DNA, pcDNA1ARtkpA, was
added to obtain equimolar quantities of CMV-promotor-
containing constructs. In addition, pUC19 DNAwas added
to obtain a final concentration of 2.5 μg of DNA per well.
Mock-transfected cells were transfected with empty vector
DNA, pcDNA1ARtkpA. The transfections were performed
according to the manufacturer’s instructions.
Phosphate Uptake
Cells seeded in four-well plates and transfected as described
above were incubated for 48 h after the transfection. The cells
were washed in 37 °C pre-warmed Pi-free DMEM medium
(Gibco) and thereafter incubated at room temperature for
5 min in 37 °C pre-warmed Pi-free DMEM supplementedwith
KH2
32PO4 (NEX060, 1 Ci/mmol, Perkin Elmer) and cold Pi
added to a final concentration of 1 mM Pi. They were then
washed in 3× ice-cold 0.9% NaCl and lysed with 0.5% Triton
X-100. One third of each lysate was transferred to counting
vials, mixed with 5 mL liquid scintillation cocktail (Optiphase
Hisafe 3 (Perkin Elmer)), and counted in a liquid scintillation
counter. Dilution series of 32Pi were counted simultaneously.
The remaining lysates were stored at −20 °C for later protein
determination using the BCA™ Protein Assay Kit (Pierce).
Statistics
Data are presented as mean ± standard deviation (SD). As
these types of experiments can be prone to large variations,
the modified Thompson tau technique was applied; one outlier
in the experiment shown in Fig. 1b was discarded (p ≤ 0.01).
The hypothesis that twomean values were identical was tested
by a two-tailed Student’s t test; a p value ≤0.05was considered
statistically significant. Bonferroni-Holm correction was per-
formed to avoid α-error accumulation (Holm 1979).
Results
In order to address whether a Pi-transport-incompetent
PiT2 variant can affect the Pi-transport function of the
WT PiT2 prote in in mammal ian ce l l s , we used
PiT2E575K, which has been reported in a Spanish family
as well as in a sporadic case and experimentally verified
to be Pi-transport incompetent (Bøttger and Pedersen
2002; Schottlaender et al. 2012; Wang et al. 2012). To
simulate the effect of a monoallelic variant in the
SLC20A2 gene and thus mimic the PBC disease situation,
we used cells (3463T3) isolated from a Slc20a−/− mouse
and co-transfection of vectors expressing variant and WT
human PiT2 proteins; the 3463T3 cells do not express
endogenous PiT2 in the plasma membrane (Jensen et al.
submitted manuscript). Transient transfection of the ex-
pression vector encoding WT PiT2 (pOJ74) was suffi-
cient to obtain an increased Pi-uptake ability of 3463T3
cultures (compare pOJ74 and mock- and non-transfected
in Fig. 1). Co-transfection of the WT PiT2-encoding vec-
tor (pOJ74) with equimolar amounts (1:1) or three (1:3)
or four (1:4) times more of the PiT2E575K-encoding vec-
tor (pOJ74E575K), however, resulted in significant de-
creases in the Pi-uptake ability of the cultures compared
to cultures transfected with only WT PiT2-encoding vec-
tor (pOJ74) (Fig. 1a). To analyze whether the presence of
PiT2 proteins with other missense variants can mitigate
the WT PiT2-mediated Pi-uptake ability when expressed
in a mammalian cell, PiT2D28N and PiT2H502A were
employed. The D28N variant has been reported in two
sporadic cases of PBC (Chen et al. 2013; Nicolas et al.
2013a), and the H502A mutation was employed to repre-
sent a reported variant of H502 in PFBC (H502Q in
PFBC) (Hsu e t a l . 2013) . Both PiT2D28N and
PiT2H502A have been shown to be unable to support Pi
uptake in Xenopus oocytes (Bøttger and Pedersen 2005,
2011). Like E575 and D28, H502 also shows a high de-
gree of phylogenetic conservation, and it is part of the C-
terminal PiT family signature sequence. Co-transfection
of equimolar amounts (1:1) of the PiT2D28N- or
PiT2H502A-encoding vectors (pOJ74D28N and
pOJ74H502A, respectively) with the WT PiT2-encoding
vector (pOJ74) also resulted in significant decreases in
the Pi-uptake ability of the cultures compared to cultures
transfected with only WT PiT2-encoding vector (pOJ74)
(Fig. 1b). Hence, these results show that the presence of a
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Pi-transport-incompetent PiT2 protein can exert a domi-
nant negative effect on WT PiT2-mediated Pi-uptake in
mammalian cells.
Discussion
The here observed dominant negative effects of Pi-trans-
port-incompetent PiT2 proteins on WT PiT2 Pi-transport
function, when transfected in equimolar amounts, show
that expression of PiT2 variants associated with familial
and sporadic PBCs can exert dominant negative effects
on WT PiT2 Pi-transport function in mammalian cells.
Thus, these results suggest that in association with PBC,
the investigated variants can result in a more severely
impaired cellular Pi-transport function than mere lack of
expression of a functional protein from one allele, i.e.,
haploinsufficiency.
PiT2 is also a receptor for gammaretroviruses (Kavanaugh
et al. 1994; Miller and Miller 1994; van Zeijl et al. 1994), and
all PiT2-derived proteins analyzed in the present study support
gammaretroviral infection in mammalian cells (Bøttger and
Pedersen 2002, 2005, 2011), which is interpreted as they can
be inserted Bcorrectly^ in the plasma membrane. Since former
characterization studies suggest that WT PiT2 proteins form
functional oligomers (Salaün et al. 2002; Bøttger et al. 2006)
and that oligomerization is independent of their Pi-transport
function per se (Salaün et al. 2004), we suggest that
oligomerization of WT and Pi-transport-incompetent PiT2
proteins is the underlying basis for the dominant negative
effect on WT PiT2 Pi-transport function observed in the pres-
ent study.
A recent publication on an autopsied PFBC patient hetero-
zygous for a SLC20A2missense variant (p.Ser637Arg) report-
ed in two Japanese families is indeed congruent with a dom-
inant negative effect exerted by a PiT2 variant protein
(Yamada et al. 2014; Kimura et al. 2015). Kimura et al. found
PiT2 expression to range from severely reduced to absent in
samples from the frontal cortex, putamen, and cerebellum, i.e.,
the PiT2 protein amount was more than halved. Mere
haploinsufficiency is expected to lead to at the most halved
expression levels or less than halved due to putative compen-
satory upregulation of expression. The most likely explana-
tion for the severely reduced PiT2 amount reported for the
patient is that WT PiT2 protein oligomerized with the variant
PiT2 protein is recognized as a misfolded confirmation by the
cells and degraded.
Both the PiT2E575K and the PiT2D28N variants analyzed
here have been found in two independent cases, which are
likely unrelated based on their ethnic origin (Schottlaender
et al. 2012; Wang et al. 2012; Chen et al. 2013; Nicolas
et al. 2013a; Westenberger and Klein 2014; Lemos et al.
2015). Nevertheless, the small number of PFBC and sporadic
PBC cases linked to the various SLC20A2 variant types and
the high degree of variation in onset of symptoms and their




























































































































Fig. 1 Co-expression assays. Cells were seeded at 1.5 × 104 cells/cm2 in
four-well plates. The following day, they were transfected withWT PiT2-
encoding vector, pOJ74, and vectors encoding the Pi-transport-
incompetent a PiT2E575K (pOJ74E575K) or b PiT2D28N
(pOJ74D28N) or PiT2H502A (pOJ74H502A) as indicated. Mock-
transfected: cells transfected with empty vector DNA. Ratios refer to
the ratio between vectors encoding WT and Pi-transport-incompetent
PiT2, where 1 represents 0.05 μg DNA. Emtpy expression vector and
plasmid DNAs were included to ensure equimolar amounts of expression
vector and same amount of DNA, respectively, in the transfections.
Approximately 48 h after transfection, the cells were incubated in
transport medium containing a total [Pi] of 1 mM and the import of
32Pi
was analyzed over 5 min. Results are shown as mean Pi uptake per
microgram protein per hour of at least three wells; error bars represent
SDs. Asterisk indicates p ≤ 0.05 relative to cells expressingWT PiT2 only
(pOJ74 (1:0) (leftmost column))
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et al. 2013a; Westenberger and Klein 2014; Yamada et al.
2014; Lemos et al. 2015; Nicolas et al. 2015), make studies
of variant–phenotype correlations difficult. However, results
from in vitro studies, as the present study, and animal studies
can provide insight into potential disease mechanisms and the
specific roles of PiT2. It was recently shown by Jensen et al.
that the CSF of 3-week-old Slc20a2−/− mice on average had
more than twofold elevated [Pi] compared toWTmice (Jensen
et al. 2016). Wallingford et al. have later reported similar find-
ings in 1-year-old Slc20a2−/−mice, while Slc20a+/−mice were
found to show an intermediate CSF [Pi] albeit not statistically
significantly different from WT mice (Wallingford et al.
2016). The elevated [Pi] in the CSF is ascribed to a function
of PiT2 in the choroid plexus as an exporter of Pi from the
CSF (Guerreiro et al. 2014; Jensen et al. 2016; Wallingford
et al. 2016). In PBC patients, a missense variant exerting a
dominant negative effect could result in a potentially more
severe outcome than haploinsufficiency with respect to eleva-
tion of the CSF [Pi] as well as with respect to the putative
direct effect on the cells of the brain. In addition, compared
to Slc20a2−/− mice, Slc20a2+/− mice show significant less
(Wallingford et al. 2016) or rarely (Jensen et al. submitted
manuscript) brain calcification and at later ages (Jensen et al.
2013; Wallingford et al. 2016) (Jensen et al. submitted manu-
script). And while there is a high degree of variation in the
degree of calcification and the manifestation of symptoms
even within PFBC families (Hsu et al. 2013; Nicolas et al.
2013a; Westenberger and Klein 2014; Yamada et al. 2014;
Lemos et al. 2015; Nicolas et al. 2015), there is a correlation
between the total calcification score and presence of symp-
toms (Nicolas et al. 2013a; Nicolas et al. 2015). Thus, mis-
sense variants exerting a dominant negative effect might con-
tribute to an earlier disease onset and/or a more serious phe-
notype than variants, which cause monoallelic lack of expres-
sion of functional protein.
In conclusion, our results strongly indicate that the molec-
ular mechanism of disease in familial and sporadic PBCs
might not be ascribed solely to haploinsufficiency. Missense
variants in SLC20A2 linked to the disease have here been
shown to exert a dominant negative effect on WT PiT2-
mediated cellular Pi uptake. PiT2 proteins can oligomerize,
and the variant proteins might exert their dominant negative
effect, either by reducing the amount of Pi-transport-capable
PiT2 oligomers in the cell membrane and/or, as observed by
Kimura et al. (Kimura et al. 2015) in a PFBC patient, by
reducing the amount of WT and variant PiT2 proteins in the
cells.
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